Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

IKT — Inhibikase Therapeutics, Inc. Dilution Risk Tracker

Track IKT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IKT — Get alerts when the score changes →

As of October 13, 2026, Inhibikase Therapeutics, Inc. (IKT) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Inhibikase Therapeutics, Inc. has a market capitalization of $257.44M, 139.54M shares outstanding, 104 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.79 approaching $1 threshold
🔔 Track IKT — Get forecast alerts →

Market Data

Market Cap$257.44M
Shares Outstanding139.54M
Float86.88M
Cash$306.61M
Debt$381.8K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding139.54MVerified float table or market cache
Public Float86.88MVerified float table or market cache
Market Cap$257.44MMarket data cache
Cash Runway141.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 9.6% shares (2026Q1 vs prior)
104 institutional holders · 125.60M shares
#1 Sands Capital Alternatives, LLC 13.02M shares
#2 Soleus Capital Management, L.P. 10.88M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 8.90M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.43M
Days to Cover27.0
% of Float22.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-26
xbrl XBRL CONVERTIBLE 2022-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual IKT Dilution Snapshot

Inhibikase Therapeutics, Inc. (IKT) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

IKT's DilutionScore is currently 32/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 35/100 (Medium risk).

Period Score Risk Level Duration
Sep 27 – Oct 13, 202632/100MEDIUM17 days
Sep 23 – Sep 26, 202635/100MEDIUM4 days
Aug 14 – Sep 22, 202632/100MEDIUM39 days
Jul 16 – Aug 13, 202628/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

IKT shares outstanding have decreased 0.0% from 132.03M (Mar 2026) to 132.03M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 2026132.03M86.88M▼ 0.02%
May 01, 2026132.03M86.89M▲ 1.71%
Apr 26, 2026132.03M85.43M▲ 0.02%
Apr 03, 2026132.03M85.42M▲ 33.26%
Mar 30, 2026132.03M64.10M▲ 2.96%
Mar 28, 2026132.03M62.26M▲ 41.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track IKT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment IKT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking IKT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IKT
IKT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.